[CaRP] php_network_getaddresses: getaddrinfo failed: Temporary failure in name resolution (0) Albuminuria news from AusAm Biotechnologies, Inc. News from the company that developed the Accumin(tm) Total Intact Albumin Assay(tm) for early detection of microalbuminuria, a key indicator of risk for kidney disease and cardiovascular disease. Copyright 2005 by AusAm Biotechnologies, Inc. All rights reserved.
Microalbumin Plus Measures Urine Protein Undetected by Current Tests
Microalbumin Plus Measures Urine Protein Undetectable by Current Tests
Experts from around the world to lead discussions on the importance of a urinary protein in the identification and treatment of kidney and cardiovascular disease
Society to Collaborate with National Kidney Foundation on Event to Discuss the Importance of the Protein Albumin in Disease Identification and Prevention
World Renowned Experts Gather to Discuss the Importance of the Protein Albumin in Disease Detection
Event Will Involve Experts in Many Fields from Around the World to Discuss the Importance of Identification of Urinary Protein for Diabetics
Former Quest Diagnostics President Brings More Than Twenty Years of Experience to AusAm
Grant Will Speed Development of a Topical Drug to Protect from HIV and Sexually Transmitted Infections
Study Shows Variation between Conventional Urine Testing and Accumin for Measuring Urine Protein Albumin
Provides the First Direct Total Intact Measurement of Protein Albumin in Urine
Medical Professionals Gather to Discuss the Important Role of the Protein Albumin in Disease Detection
American Society of Hypertension and European Society of Hypertension Recognize Importance of Identification of Urinary Protein in Prevention of Heart Disease Newsfeed display by CaRP |
